Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy
暂无分享,去创建一个
J. Lewis | B. Wolffenbuttel | D. de Zeeuw | S. Bakker | R. Gansevoort | H. L. Lambers Heerspink | P. Vart | H. Lutgers | E. Schutte | K. Umanath | Elise Schutte